🔎 Trials Near Me

Domov › Ulcerózna kolitída › Indiana

Klinické štúdie Ulcerózna kolitída v štáte Indiana

10 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v štáte Indiana.

Mestá v štáte Indiana

Oficiálny text štúdie (anglicky)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Gastroenterology Health Partners /ID# 284145, New Albany
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07697456

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • IU Health University Hospital, Indianapolis
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196748

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Riley Hospital for Children, Indianapolis
Prebieha náborFáza 3
Vek 3 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06663332

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Local Institution - 0100, Indianapolis
Prebieha náborFáza 2/3
Vek 2 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Indiana University Health University Hospital, Indianapolis
  • Gastroenterology Health Partners, New Albany
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Gastroenterology Health Partners, New Albany
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Health Partners, New Albany
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07415044

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100, New Albany
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07185009

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Gastroenterology Health Partners, PLLC - Site Number: 8400100, New Albany
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07184996

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

  • Bausch Health Site 003, Indianapolis
Prebieha náborFáza 4
Vek 5 až 17 · Všetky pohlavia · Aktualizované 16. 9. 2025 · NCT04314375

Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.